ChemicalBook > Product Catalog >Organic Chemistry >Heterocyclic Compounds >2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel-

2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel-

Request For Quotation
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel- Suppliers list
Company Name: AbaChemScene  
Tel: 732-484-9848
Email: sales@chemscene.com
Company Name: Shanghai Kaiwei Chemical Technology Co., Ltd.  
Tel: 021-58461859 15821823057
Email: service@aiviche.com
Company Name: Zibo Biopolar Rongchuang Pharmaceutical Co. Ltd.  
Tel: 0533-6092686 13371592196
Email: ddliu@bio-polar.cn
Company Name: https://hanhongsci.com/  
Tel: 021-54306202 18917919676
Email: info@hanhongsci.com
Company Name: Jilin Chinese Academy of Sciences-yanshen Technology  
Tel: 18143011203
Email: ET-market@chemextension.com
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel- Basic information
Product Name:2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel-
Synonyms:2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel-;rel-(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione;(rel)-Tivantinib
CAS:905853-99-8
MF:C23H19N3O2
MW:369.42
EINECS:
Product Categories:
Mol File:905853-99-8.mol
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel- Structure
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel- Chemical Properties
Boiling point 715.9±60.0 °C(Predicted)
density 1.49±0.1 g/cm3(Predicted)
pka9.28±0.70(Predicted)
form Solid
color Off-white to pink
Safety Information
MSDS Information
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel- Usage And Synthesis
Uses(rel)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (rel)-Tivantinib has two novel targets, GSK3α and GSK3β, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1].
DefinitionChEBI: LSM-1131 is a member of indoles.
References[1] Remsing Rix LL, et al. GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells. ACS Chem Biol. 2014 Feb 21;9(2):353-8. DOI:10.1021/cb400660a
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel- Preparation Products And Raw materials
Tag:2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-rel-(905853-99-8) Related Product Information
FITC-Labeled HGFR Protein, Human (HEK293, His) HGFR Protein, Rat (HEK293, Fc) Savolitinib Protein Tyrosine Kinase Compound Library Anti-cancer compound library Crizotinib